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Interchromatin granule clusters (IGC)P complex than catalyses the removal of introns from the Uridine-rich small
nuclear ribonucleoproteins (U snRNPs) that make up the main components of this complex. The production
of these RNPs is an intricate process, involving several key stages. These include: 1) the transcription of the U
snRNAs; 2) their nuclear export; 3) the cytoplasmic assembly of the U snRNP; 4) their nuclear import; 5) their
processing within Cajal bodies and the nucleolus; and 6) their storage in interchromatin granule clusters
(IGCs). This review focuses on each of these stages, discussing the key complexes involved as well as the
trafﬁcking and targeting mechanisms involved.
© 2008 Elsevier B.V. All rights reserved.RNA splicing is the process of removing introns from a
transcribed heterogeneous nuclear RNA (hnRNA) (pre-mRNA)
molecule [1]. This process is accomplished by the spliceosome, a
large (40s) RNA/protein macromolecular machine [1]. The spliceo-
some is made up of 5 major building units termed U1, U2, U4, U5
and U6 small nuclear ribonucleoproteins (snRNP) [1]. These U
snRNPs are made up to a complex of RNA and proteins, containing
U snRNA (Uridine-rich small nuclear RNA), Sm proteins (7 core
proteins; Sm B or B′, D1, D2, D3, E, F and G) that are common to all
snRNPs and several other proteins that are speciﬁc for each U
snRNP [1]. The assembly of the spliceosome is a complex process
that requires shuttling between the nucleus and the cytoplasm (Fig.
1) [1]. Initially the U snRNAs are synthesised in the nucleus, then
are required to move to the cytoplasm for assembly into U snRNPs
before returning to the nucleus where they mature in Cajal bodies
and nucleoli and then transfer to splicing interchromatin granule
clusters (IGCs) and perichromatin ﬁbrils (PFs) to participate in
splicing (Fig. 1) [2]. In this review we will discuss the production of
these U snRNPs, including their transcription, nuclear export,
cytoplasmic assembly, nuclear import and sub-nuclear targeting..
l rights reserved.1. U snRNA transcription
U1, U2, U4, and U5 snRNAs are synthesised in the nucleus by RNA
polymerase II. 7-methylguanosine (monomethyl-cap; mG) cap struc-
tures are added co-transcriptionally to all RNA polymerase II
transcripts, which acts as one of the signals for nuclear export [3].
U3 snRNA is also transcribed by RNA polymerase II and participates in
rRNA processing in the nucleus [4] and belongs to a group of three
snoRNAs (U3, U8 and U13) [5]. U6 is transcribed by RNA polymerase III
[6]. The mG cap structures are involved in several processes including
RNA stability [7–10], pre-mRNA splicing [3,11–15], translation initia-
tion [16,17], and RNA export from the nucleus [18–20]. U1, U2, U4 and
U5 snRNA are all transcribed by RNA polymerase II and so contain this
cap structure, which is required for their export from the nucleus to
the cytoplasm across the nuclear membrane where they are required
for U snRNP assembly.
2. Architecture of the nuclear membrane
The nuclear membrane represents the interface between the
nucleus and cytoplasm, and is essential for maintaining the unique
identity of each compartment [21,22]. The membrane is composed of
three main components, the lamina, the nuclear membranes and the
nuclear pore complexes (NPCs). Each NPC is composed of building
blocks of ∼30 different proteins called nucleoporins (nups), which are
assembled to form sub-complexes within the NPC [23,21]. Analysis of
Fig. 1. Schematic overview of the production and processing of U snRNPs. Newly transcribed U snRNA containing a 5′ monomethyl-guanosine (mG) cap (1) is actively transported
through the nuclear pore complex (2) into the cytoplasm. Here the Sm core proteins are assembled onto the U snRNA (3) to form the U snRNP. Once the Sm core assembly has taken
place the 5′ guanosine cap is methylated to form a trimethylated guanosine cap (m3G) (4). The m3G and Sm core complex function as a bipartite signal and mediate the nuclear
import of the U snRNP (5).
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remains difﬁcult due to the complex nature of the NPC and limitations
in current experimental approaches [23].
The nuclear lamina is essential for nuclear integrity and is
composed of intermediate ﬁlaments made up of lamins and lamin-
associated proteins. These proteins include the lamin-associated
protein (LAP) 1 and 2 families, the lamin B receptor (LBR), and
Emerin [24,21]. In vertebrate somatic cells, this is a 10–20 nm thick
protein meshwork, underlying the INM, and is composed primarily
of A and B type lamins [25]. Lamins are members of the Intermediate
Filament (IF) family, and feature a coiled coil ﬂanked by non-helical
tail and head domains [22]. There are a group of genetic disorders
associated with mutations in lamin proteins and lamin-binding
proteins termed laminopathies or the more generic term nuclear
envelopathies. The most common nuclear envelopathy with the
highest frequency in human populations is Emery–Dreifuss muscular
dystrophy, caused by an X-linked mutation in the EMD gene coding
for emerin, a lamin-binding protein and affects an estimated 1 in
100,000 people [26].
The nuclear membranes are two morphologically different, but
interconnected domains named the outer nuclear membrane (ONM)
and the inner nuclear membrane (INM). The ONM is continuous
with the rough endoplasmic reticulum (rER), has ribosomes
attached [21,27,28], and provides attachment sites for structural
elements of the cytoplasm [21,29,30]. The INM contains a unique set
of proteins that are involved in binding for lamina and chromatin
[21,31–33]. The ONM and INM are separated by the perinuclear
space (PNS), which is a regular gap of 30–50 nm, and an extensionof the ER lumen [22]. Junctions between the ONM and INM form
channels capable of mediating selective exchange of macromo-
lecules. These proteins are called the nuclear pore complexes (NPC)
[22].
3. The nuclear pore complex (NPC)
The NPC are pore-like discontinuities within the nuclear envelope,
and are the siteswhere nucleocytoplasmic exchange occurs [34,35,28].
NPCs are made up of large proteinaceous assemblies (nucleoporins) of
approximately 120 MDa and are able to selectively transport cargoes
across the nuclear envelope [23]. The NPC acts almost like a sieve,
allowing smallmolecules and ions todiffuse through theNPC, however
the transport of large macromolecular assemblies (e.g. proteins, RNAs
and RNPs) is dependent on their recognition by transport factors,
which are able to interact with the NPC and carry their cargos across
the nuclear envelope [22,36–38]. Fig. 2 shows a schematic representa-
tion of the NPC. The vertebrate NPC has a tripartite architecture,
consisting of a central framework that is decorated by cytoplasmic
ﬁlaments and a nuclear basket (Fig. 2) [39]. The three dimensional
structure of the NPC represents an eightfold rotational symmetry
perpendicular to the nuclear membrane [40].
To pass through the NPC, transport receptors are required to bind
to FG nucleoporin (nups) docking sites to trigger channel gating [41].
FG nups contain repeating amino acid sequences, predominantly FG,
GLFG or FxFG, separated by hydrophilic and charged amino acid
linker sequences [42]. FG nups are highly disordered and ﬂexible
with little secondary structure, and form a mesh work of random
Fig. 2. Diagrammatic explanation of Ran's role in nuclear import and export of receptor bound protein translocation. Hydrolysis of GDP bound to GTP bound Ran by RCC1 promotes
release of transport receptors and cargo into the nucleus. Conversion of GTP bound to GDP bound ran by RanGAP1 in the cytoplasm initiates release of receptor and cargo complexes
in the cytoplasm.
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the NPC [42,43].
4. Nuclear export of the U snRNAs
Nuclear export of the U snRNAs through the NPC is dependent
upon the interaction between the U snRNA mG cap structure and the
nuclear cap binding complex, the export receptor CRM1/XpoI and
RanGTP [16,44]. The nuclear cap binding complex (CBC) is a
heterodimeric complex composed of two subunits, cap binding
protein 80 (CBP80) and cap binding protein 20 (CBP20). Both of
these subunits are required for binding to the mG cap structure
[16,45–47]. A study by Izaurralde in 2002 [48], found that antibodies
raised against recombinant CBP20 prevented the interaction of the
CBC with capped RNAs in vitro. The antibodies inhibited both pre-
mRNA splicing and export of U snRNA to the cytoplasm. CRM1/Xpo1 is
also the export receptor for proteins carrying leucine-rich nuclear
export signals (NESs) [14]. CRM1 was identiﬁed as an export receptor
for U snRNA export in a study by Fischer et al. [11]. They speciﬁcally
inhibited U snRNA export by inactivating CRM1 with the unsaturated,
branched-chain fatty acid leptomycin B, thereby saturating CRM1with
an excess of NES peptides [11,14]. CRM1 is also heavily involved in the
nuclear trafﬁcking of mature U snRNPs [93], but this will be discussed
later (Fig. 4).
The small GTPase, Ran, is an essential factor for nuclear protein
export [49]. Ran is predominantly found in the nucleus and its activity
is controlled by a nuclear, chromatin associated, guanine-nucleotide
exchange factor, RCC1, and by a cytoplasmic GTPase activating protein,
RanGAP [50,51]. Fig. 2 shows a schematic representation of the role of
Ran in nuclear import. The distribution of these two proteins would
suggest that nuclear Ran is predominantly loaded with GTP, whereas
cytoplasmic Ran is immediately converted into the GDP bound state.
The precise function of Ran in translocation is not known, however
there is evidence that the RanGTP/RanGDP gradient between the
nucleus/cytoplasm could drive the direction of import, as RanGDP
mediates import, whereas RanGTPmediates export [52]. However it is
known that Ran is involved in the release of cargo/receptor complexes,for example, RanGTP induces release of both importin α from β in the
classic NLS signal protein import and also release of M9 signals from
transportin [52]. RanGTP is also thought to alter the NPC conformation
during transportation, by reducing NPC internal diameter by causing
the cytoplasmic ﬁlaments to extend and inhibit import [53].
Hydrolysis of GTP by Ran is therefore required to allow release of
import substrates, bound to the ﬁlaments, to be released into the NPC
[53]. Ran has a low intrinsic activity, needing both the Ran-
GTPase-activating protein (RanGAP) and the co-activator Ran-binding
protein 1 (RanBP1) to achieve maximum GTPase activity. As both of
these are located in the cytoplasm, the majority of Ran in the nucleus
is believed to be in the RanGTP form [54].
A further protein thought to be involved in U snRNA export is the
phosphorylated adaptor for RNA export protein (PHAX) [47]. Ohno
et al. demonstrated that PHAX is used as an adaptor molecule to aid
the binding of CRMI/RanGTP proteinwith the CBC/RNA complex using
mobility shift assays and phosphorylation inhibitory studies [47].
PHAX is phosphorylated in the nucleus and this phosphorylation is
essential for export complex assembly. PHAX is exported with RNA to
the cytoplasm, where it is dephosphorylated. This dephosphorylation
causes the export assembly to disassemble [47]. Fig. 2 shows a
diagrammatic explanation of U snRNA nuclear export.
5. Cytoplasmic assembly of U snRNPs
Once the U snRNA/CBC/PHAX/CRM1/RanGTP complex has entered
the cytoplasm, the complex dissociates. The Ran-GTPase activator
protein (RanGAP) and the co-activator, RanBP1, mediate this dissocia-
tion. In their presence, the Ran-GTPase activity is maximised, resulting
in hydrolysis of the GTP to GDP providing the energy for the release of
the snRNA [54]. The RanGDP is then transported back into the nucleus
attached to the CRM1 receptor [54]. Dephosphorylation of PHAX may
also be involved in dissociation of the export complex [47].
Once the U snRNAs are freed, cytoplasmic assembly of the snRNPs
can occur. The protein components of the U snRNPs can be divided
into two groups. The ﬁrst includes proteins such as U1A, U170K, U2B″
and U2A that are speciﬁc to certain U snRNA subclasses. The second
Fig. 3. Schematic representation of the U snRNP bipartite import complex. The bipartite
signal involves trimethylated guanosine (m3G) cap associated with snurportin1 and
importin β, and the proposed SMN dependent Sm core protein import, which
associated either directly or indirectly with importin β and Ran. Although this
schematic shows SMN interacting directly with importin β, this proposed import signal
may involve an as yet unidentiﬁed import adaptor.
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with systemic lupus erythematosus who produced autoantibodies
against the proteins [55,56]. In the majority of adult mammalian cell
types there are eight common core proteins, B, B′, D1, D2, D3, E, F and G.
The eight proteins are encoded by seven different gene; B and B′
proteins are alternatively spliced products of a single gene, differing
only in their carboxyl-terminal part [57]. The Sm binding motif
(5′-Pu-A-U3–6-G-Pu-3′, where Pu represents a purine nucleotide) is
highly conserved across species, with the adenosine residue in
position 2 present in 95% of characterised animal species [58]. In
adult neuronal cells and to a lesser extent in myocardial cells, the B/B′
proteins are replaced by a ninth core protein, the N protein [59,60]. It
is believed that an ancestral gene duplication gave rise to the N protein
as B′/B share 98% homology to the N protein [59].
Newly synthesised Sm proteins are stored in four partially
assembled cytoplasmic complexes that are snRNA-free [61,56].
These are: (1) a (E.F.G)2 hexameric complex; (2) a 20S complex
consisting of D3.B and an uncharacterised 70 kDa protein; (3) a
complex of 2–6S consisting of (B)n; and (4) a D1.D2 complex
[56,61–64]. An additional 6S complex consisting of D1.D2. (E.F.G)2,
has also been identiﬁed in the cytoplasm, although this complex is less
stable than either the (E.F.G)2 hexameric complex or the D1.D2
complex [61,63]. All Sm core proteins contain two conserved motifs,
Sm1 and Sm2. Sm1 contains strands β1–3, whilst Sm2 contains β4 and
β5 [65,66]. Kambach et al. found that an extended anti-parallel
β-sheet formed between strands β4 of the B protein and β5 of the D3
protein mediates the formation of the D3B heterodimer. Similar
β-sheet interactions were observed between D1and D2, where β4 of
the D2 protein pairs with β5 of the D1 protein [66].
The assembly of the Sm core complex is believed to be a step-wise
ordered process [67]. The initial step involves the E.G.F and D1D2
complexes interacting with the conserved 5′-Pu-A-U3–6-G-Pu-3′ Sm
binding motif of the U snRNA to form a stable intermediate molecule
called the subcore snRNP [63]. Once the subcore has been formed the
D3.B/B′ complex binds to form the complete U snRNP molecule.
6. The role of the SMN complex in U snRNP
The survival motor neuron (SMN) protein has been implicated in
the cytoplasmic assembly of the U snRNPs [68]. The SMN protein is a
ubiquitously expressed RNA processing factor. Reduced levels of the
SMN protein trigger the neurodegenerative disorder, spinal muscular
atrophy (SMA) [69]. The SMN protein is part of a largemacromolecular
complex, termed the Gemin complex [68]. This complex consists of
SMN, Gemin2, Gemin3, Gemin4, Gemin5, Gemin6, Gemin7 and
Gemin8. The Gemins predominantly co-localise with SMN in nuclear
Cajal bodies and also in the cytoplasm, where they also associate with
the Sm core proteins [70], and with the U snRNAs [71]. There is a
growing body of evidence demonstrating the SMN complex plays an
integral role in the cytoplasmic assembly of the U snRNPs. Early
experiments on oocytes demonstrated that functionally blocking the
SMN protein with microinjected antibodies inhibited core protein
assembly on U1 snRNA [72]. In addition, reducing the levels of SMN,
Gemin2, Gemin3, and Gemin4 proteins using interfering RNA (RNAi)
all independently inhibit U snRNP assembly to some degree [73]. It is
known that the core proteins interact directly with several members
of the SMN complex, and that the U snRNA interacts directly with
Gemin5. This may suggest that the complex forms a scaffold that
facilitates the assembly process. In addition, mutational analysis
studies on U snRNA demonstrate that the SMN complex may function
in a “quality control” role, by ensuring assembly only occurs on
functional U snRNA [71].
Once the core domain has been assembled the 5′ mG cap is
hypermethylated, forming a 2,2,7-trimethyl-guanosine (m2,2,7G; m3G)
cap. This modiﬁcation can only occur after the core complex has been
assembled [74]. The mature Sm core domain provides a binding sitefor an RNA methyltransferase, which catalyses formation of the tri-
methyl-guanosine (m3G) cap of the U snRNA via hypermethylation.
The assembled particle is then transported actively to the nucleus
[75,76]. Following assembly of the U snRNP they are required in the
nucleus for splicing.
The import is controlled by a bipartite import signal consisting of
the assembled Sm core complex and the m3G cap. By deﬁnition,
independently neither of these signals is sufﬁcient tomediate efﬁcient
import. The more extensively studied pathway is the use of the
m3G cap as a nuclear targeting signal. This pathway utilises snurportin
1 (SPN1) as an adaptor molecule [19]. The SPN1 molecule binds to
both the m3G cap and the importin βmolecule. The importin β is able
to mediate the interaction with the NPC and translocates the U snRNP
import complex through the NPC [19,77]. Studies by Humber et al. and
Rollenhagen et al. found that the m3G cap dependent import required
importin β but not Ran or energy [76,78].
The second pathway for U snRNP import is the use of the Sm core
domain of U snRNPs formed by Sm proteins. This needs to occur for
the hypermethylation of the (m3G) cap. This pathway again utilises
importin β as a receptor for import, but also requires an unidentiﬁed
adaptor molecule. Potentially, SMN could function as the adaptor
(Fig. 3). In keeping with this, the nuclear import of both SMN and U
snRNPs are co-dependent, withmutations in either Sm core protein or
SMN preventing the efﬁcient import of both [77].
7. Maturation of U snRNPs
Once in the nucleus, binding of RanGTP to the import complex
triggers dissociation and release of the U snRNP [79]. The absence of
the m3G cap on the U snRNP ensures nuclear retention and
snurportin1 is transported back into the cytoplasm in association
with CRM1 [80]. Unlike the cytoplasm, the nucleus is not compart-
mentalised into membrane bound organelles. However, many nuclear
antigens are localised in different sub-nuclear structures, distinct from
the surrounding nucleoplasm [81,82]. Nuclear bodies include nucleoli,
sites of ribosome production and RNA metabolism and transport
[83], Cajal bodies (coiled bodies), Gemini of Cajal bodies (gems),
promyelocytic leukaemia (PML) bodies, IGCs, interchromatin-
granule-associated zones and PFs [84] and references therein.
Antibody staining of Sm proteins demonstrates that snRNPs have a
complex nuclear localisation [85]. Once imported to the nucleus,
snRNP particles are seen to interact with different sub-nuclear
structures, including IGCs, PFs and Cajal bodies [85]. Targeting to
these bodies is not a random event, but follows a clear step-wise
pathway. Initially, newly imported U snRNPs are targeted to Cajal
bodies (Fig. 4). From here, they then pass through the nucleolus, then
back to the Cajal bodies and ﬁnally on to the IGCs (Fig. 4). The central
Fig. 4. Schematic representation of the factors mediating the sub-nuclear targeting of U snRNPs. Newly imported U snRNPs are initially targeted to Cajal bodies (1). This process is
mediated through an associationwith SMN, p80-coilin, ZPR1 and CRM1. The U snRNPs are then processed through the nucleolus (2), before returning to the Cajal bodies (3). Targeting
to the nucleolus is depended on SMN, p80-coilin and Nopp140, while returning to Cajal bodies is controlled by SMN, p80-coilin, Nopp140 and protein phosphotase 4 (PP4). Finally,
U snRNPs are targeted to the interchromatin granule clusters (IGCs; 4) through an association with SMN, CRM1 and p80-colin.
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primary cellular role is the sorting and processing of snRNPs.
8. Mature U snRNPs accumulate in Cajal bodies
Unlike the mG cap associated with the immature U snRNA, both
the m3G cap and the Sm core proteins (B, B′, D1, D2, D3, E, F and G)
have been detected in coiled bodies [86–88]. This suggests that U
snRNPs, which have passed through the cytoplasmic maturation
stage, accumulate in Cajal bodies, but nascent snRNA transcripts do
not. Targeting of the spliceosomal U snRNPs to coiled bodies appears
to be mediated through a coiled body marker protein, coilin p80 (Fig.
4) [89]. Coilin p80 is an 80 kDa protein that is ubiquitously expressed
in mammalian cells [90]. Coilin p80 contains two nuclear localisation
signals (NLS). However, mutational analysis studies show that on
their own these NLSs are not sufﬁcient to target coilin p80 to Cajal
bodies [90].
Cajal bodies still form in the absence of coilin p80, but they do not
contain either the Sm core proteins or mature U snRNPs [89]. In cells
immunodepleted for the Sm core proteins, coilin p80 levels in Cajal
bodies are also reduced [89]. This suggests that coilin p80 and the
U snRNPs are co-dependent on each other for Cajal body targeting.
Although coilin p80 contains two nuclear localisation signals, it does
not co-localise with U snRNAs or U snRNPs in the cytoplasm [89]. This
suggests that coilin p80 has no role in either cytoplasmic maturation
or nuclear import of the U snRNPs. However, it is possible that coilin
p80 and the snRNPs form a complex once the snRNPs have been
released from the import complex and it is this nuclear complex that
mediates sub-nuclear distributions. Coilin p80 is known to be an SMN
binding partner [91,92]. Furthermore, symmetrical dimethylation ofthe RGG-motifs of coilin p80 trigger the merging of Cajal bodies with
their closely associated SMN-positive loci, Gemini of coiled bodies
[91,92]. This process occurs during development in mammalian cells,
with gems and Cajal bodies appearing as distinct sub-nuclear bodies
in fetal tissue, while the two are almost completely merged in adult
cells [93]. This suggests that SMN not only mediates nuclear import of
the U snRNP, but may also be involved in Cajal body targeting through
an associationwith coilin p80 (Fig. 4). In keepingwith this, a truncated
SMN protein lacking the ﬁrst 28 amino acids inhibits Cajal body
targeting of the U snRNPs [94]. This targeting also appears to involve
the nuclear export adaptor, CRM1 (Fig. 4), which interacts with both
SMN and the Sm core proteins [2], and the zinc-ﬁnger binding protein,
ZPR1 (Fig. 4) [95].
Within the SMN protein several core internal targeting sequences
have recently been identiﬁed. These include the domains encoded
by exons 2b, 3 and 6 [96]. Removal of any of these domains
prevented Cajal body targeting of the SMN protein. Exons 2b and 6
encode self-association domains, while exon 3 encodes the Tudor
domain, suggesting that self-association and RGG-motif binding play
an integral role in Cajal targeting of SMN [96]. As several Sm core
proteins contain RGG-domains, these observations suggest that an
association with U snRNP may in part mediate SMN targeting to
Cajal bodies.
9. Nucleolar processing of U snRNPs
Antibodies against the m3G cap of mature snRNPs and coilin p80
showed that low levels of U snRNPs are present in the nucleolus of
HeLa cells [97] and yeast cells [98]. This led to the suggestion that
although U snRNPs and/or coilin p80 do not accumulate in the
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ration stage [97,99]. U6 snRNA localises to nucleoli where it undergoes
2′-O-methylation and pseudouridylation of deﬁned nucleotides by
guide snoRNA's (as that with scaRNAs in Cajal bodies) [99]. U2, U4 and
U5 snRNA are also modiﬁed in the nucleoli [100]. Mechanism
mediating nucleoli localisation of U6 snRNA is through its 3′ nucleolar
localisation element [100].
Distribution of U snRNPs is also altered by the phosphorylation
state of coilin p80 [97]. Coilin p80 contains several serine phospho-
rylation sites [101]. Inhibition of PP1 and PP2A serine/threonine
(Ser/Thr) protein phosphatases [102] results in accumulation of coilin
p80 and U snRNPs in the nucleolus in structures resembling coiled
bodies, again highlighting their associated distribution pattern [97].
The phosphorylation state of a serine residue at position 202 of coilin
p80 has been shown to control nuclear distribution of both coilin p80
and U snRNPs [97]. Conversion of the serine to an alanine (S202A) the
methyl-R group of which mimics serine in a dephosphorylated state
targeted both molecules to the Cajal bodies. In contrast, conversion to
an aspartate (S202D), the carboxyl-R group of which simulates serine
in a phosphorylated state, resulted in a nucleolar localisation [97,103].
In accordance with the phosphorylation state mediated distribution,
a protein phosphatase 1 isoform (PP1δ) and two separate protein
kinases (PKC and PKR) have been identiﬁed in the nucleolus and coiled
bodies. This is consistent with the dephosphorylation inhibition
studies with PP1 inhibition preventing both coilin p80 and U snRNPs
from leaving the nucleolus [97]. In addition protein phosphotase 4
(PP4) has been identiﬁed as a member of the SMN complex [104]. PP4
associates directly with Gemin3 and Gemin4, and directly modulates
cellular targeting of the U snRNPs (Fig. 4) [101], again highlighting
importance phosphorylation states have on sub-nuclear targeting.
10. Dynamic interaction between the nucleolus and coiled bodies
A functional interaction between Cajal bodies and the nucleolus
is evident as over-expression of mutant coilin p80 lacking the
C-terminus disrupts nucleolar morphology [90]. Both organelles also
share several components, including ﬁbrillarin, nucleolin, topoisome-
rase I and Nopp140 [86,105]. The exact function of Nopp140 is
unknown, but it has been shown to shuttle between the nucleolus and
the cytoplasm, with the N- and C-termini encoding nuclear export and
import signals respectively, leading to a suggested role in trafﬁcking of
pre-ribosomal subunits [105]. However, as Nopp140 contains
no characterised RNA-binding motifs, interactions with ribosomal-
subunits must be with the ribonucleoproteins rather than the rRNA
molecules [105]. Nopp140 has been shown to interact directly with
coilin p80. It is therefore interesting that Nopp140, when transported
into the nucleus from the cytoplasm, passes through the nucleolus
before it localises in coiled bodies (Fig. 4).
In addition, SMN has been reported in the nucleolus [93,106]. Like
U snRNPs, SMN does not appear to accumulate in the nucleolus,
suggesting dynamic association [93,106]. However, two regions in the
SMN protein have been linked to nucleolar targeting. Expression
of the exon 2b encoded domain alone speciﬁcally targets a GFP
construct to the nucleolus [107], while removal of SMN exon 3
(SMNΔ3) also targets SMN to the nucleolus [96]. This suggests several
things: 1) that SMN exon 2b may contain a nucleolar localisation
domain; 2) that SMN exon 3 may contain a nucleolar export
sequence; and 3) SMN nuclear export is dependent on its ability to
associate with the U snRNPs. It is possible that all three of these are
correct. However, a detailed analysis of the Tudor domain highlighted
that there is no minimal domain that efﬁciently enable nucleolar
export, suggesting an intact Tudor domain is essential for nucleolar
trafﬁcking. This is not too much of a surprise, considering that
association with both U snRNPs and coilin p80 both mediate SMN
nuclear targeting, as both of these associations are mediated by the
Tudor domain. Therefore, a Nopp140/U snRNP/coilin-p80/SMN com-plex may theoretically migrate through the nucleolus prior to coiled
body accumulation (Fig. 4) [105].
Expression of a truncated Nopp140 containing only the C-terminal
portion of the protein results in the dispersal of coiled bodies and
relocation of coiled body proteins, including ﬁbrillarin, coilin p80 and
Sm core proteins/U snRNPs [105]. This suggests that the N-terminus of
Nopp140 is essential for the structural integrity of coiled bodies [105]
and that full-length Nopp140 may act as a molecular chaperone
between the nucleolus and coiled bodies. If sub-nuclear distribution is
mediated by the phosphorylation states of proteins, Nopp140 is a good
candidate for a distribution mediator, as it is potentially highly-
phosphorylated, with up to 80 Ser/Thr phosphorylation sites.
11. Interchromatin granules and interchromatin
granule-associated zones
Mature U snRNPs are efﬁciently targeted to IGCs, which are the
main nuclear storage sites of the splicing machinery. U snRNPs freely
move between the IGCs and Cajal bodies in a bi-directional manner,
and this process appears to be dependent on both SMN and CRM1
[2,94,108]. The IGCs are smaller in size than Cajal bodies and are more
numerous, with an average mammalian cell containing between 30
and 50 IGCs [109]. The low levels of poly(A)+RNA detected in IGCs and
the lack of newly transcribed RNA suggests they are not the sites of
transcription or pre-mRNA splicing [110]. Instead it is suggested that
interchromatin granule clusters are involved in both storage of
spliceosome components and spliceosome assembly [111,112]. This
would suggest that, as the spliceosome assembles on poly(A)+RNA,
the level of poly(A)+RNA in the IGCs is the limiting factor and that once
assembled the spliceosome/RNA complexmigrates to the PFs. IGCs are
associated with ﬁbrillar structures termed interchromatin granule
associated zones [110]. These zones contain both U1 snRNP and coilin
p80, leading to the suggestion that they may be involved in a ﬁnal U1
snRNP maturation step, prior to storage in the IGCs [113].
12. Protein phosphorylation mediates distribution and function of
splicing factors
As well as controlling nucleolar/coiled body shuttling, a phospha-
tase-kinase network is believed to control both localisation of splicing
factors to the IGCs and spliceosomal assembly/disassembly. U snRNPs
and non-snRNP serine/arginine rich (SR) proteins must be depho-
sphorylated to accumulate in the IGs. Inhibition of PP1 causes
localisation of both factors in irregular nuclear speckles [109]. This
may suggest that only U snRNPs that have progressed through the
nucleolar-maturation stage, and thus have been dephosphorylated by
the PP1δ phosphatase, may translocate to the IGCs, a mechanism that
would ensure that only mature U snRNPs are involved in spliceosome
formation.
13. U snRNP processing and spinal muscular atrophy
The integral role SMN plays in U snRNP assembly, processing and
trafﬁcking, suggests that spinal muscular atrophy (SMA) may be due
to a problem with RNA processing. However, pathology in SMA is
mainly restricted to the anterior horn cells of the spinal cord [114], and
therefore, is unlikely to be due to a systemic issue with processing of
the U snRNPs. It is more likely that SMN's associationwith RNPs is not
restricted to the U snRNPs. For example, SMN interacts directly with
hnRNP R, and this complex is involved in the axonal transport of
β-actin mRNA [115]. As axonal transport is restricted to neuronal sub-
types it is more likely that a breakdown in this process rather than
inefﬁcient U snRNP assembly triggers the disease pathology. However,
complete loss of SMN protein results in an embryonic lethal
phenotype, which is more conducive with loss of U snRNP as-
sembly [116]. With no SMN present, hypothetically there would be no
2143D.J. Shaw et al. / Biochimica et Biophysica Acta 1783 (2008) 2137–2144U snRNP assembly, and consequently developing cells would be
unable to splice pre-mRNA or produce protein, which is in keeping
with the lethality of this genotype, but not with the phenotype
associated with SMA. However, as the U snRNP assembly pathway is
the most accepted and understood of SMN's assigned functions, more
basic scientiﬁc research is needed to truly understand the mechanistic
cause of SMA.
14. Concluding remarks
The assembly and trafﬁcking of the U snRNPs is a complex and
rigorously controlled process. Studying this process has helped
understand the function of several key proteins. For example, CRM1,
which until recently was seen simply a nuclear export mediator, is
now known to function as a nuclear trafﬁcking protein. However,
there remain several key areas that need addressing before we fully
understand the process. Firstly, we need to functionally characterise
the role of the Gemin complex in the cytoplasmic assembly process;
does the complex form a scaffold aroundwhich the complex can form,
or does it actively catalyse the interaction? Secondly, we need to
determine whether the Gemin complex is the second import adaptor
protein, or whether this role is performed by an as yet unidentiﬁed
factor. Thirdly, we need to better understand the nucleolar processing/
maturation step. Fourthly, we need to determine why the U snRNPs
are cycled between the Cajal bodies and IGCs. Addressing these
questions will provide a comprehensive understanding of a systemic
cellular function that is essential for cell viability. They will also
expand our understanding of the SMN protein, and could help
elucidate to cause of SMA and highlight novel therapeutic targets for
this, and other disorders that involve issues with RNP assembly.
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